CEFIXIME THERAPY IN PATIENTS WITH PROVEN GONORRHEA

被引：2

作者：

BACKHAUS, A

TINZL, J

机构：

来源：

INFECTION | 1990年 / 18卷

关键词：

D O I：

10.1007/BF01644634

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Cefixime is a new third generation oral cephalosporin that exibits excellent antibacterial activity against Neisseria gonorrhoeae, including betalactamase-positive strains. In an open uncontrolled clinical trial 14 male patients suffering from acute gonorrhea, aged 23 to 48 years, were treated with a single dose of 400 mg of cefixime. All 13 fully evaluable patients were clinically and bacteriologically cured. Side effects were not reported.

引用

页码：S145 / S146

页数：2

共 7 条

[1] CEFIXIME - SPECTRUM OF ANTIBACTERIAL ACTIVITY AGAINST 16016 CLINICAL ISOLATES [J].